Efficacy of the Pre-Admission Medication List (PAML) Builder Reminder Prompts

NCT ID: NCT00657462

Last Updated: 2017-01-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

14122 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-04-30

Study Completion Date

2008-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project will study whether reminder prompts increase PAML Builder application feature utilization.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This project will study whether reminder prompts increase Pre-Admission Medication List (PAML) Builder application feature utilization. PAML Builder is an application designed and maintained by Partners Information Systems that assists clinicians in medication reconciliation - a process important for patient safety and quality of care. We have determined that several potentially helpful features of the application are not being utilized as frequently as had been expected. These features include:

1. copying the pre-admission medication list (PAML) to the clipboard
2. viewing the detailed audit trail of all changes made to the PAML
3. sorting the list of medications obtained from other electronic sources by therapeutic class.

Reminder prompts (sometimes referred to as "Tip of the Day") have been employed to increase user awareness of underutilized application features. However, anecdotally some users find them unhelpful and potentially irritating. It is therefore important to determine whether reminder prompts accomplish the stated task of increasing application feature utilization. This project will compare PAML Builder application feature utilization before and after a pilot rollout of reminder prompts to determine whether they should be implemented permanently.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Utilization of Software Application Features

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

Receives the intervention (reminders displayed at the startup of the application) for both periods (period 1 and period 2) of the study.

Group Type EXPERIMENTAL

Reminders

Intervention Type OTHER

Users of the PAML Builder application will receive reminders about three application features (copy/paste, audit trail, sort medications by class) at the startup of the application

B

Receives the intervention (reminders displayed at the application startup) only during the second period (period 2) of the study.

Group Type ACTIVE_COMPARATOR

Reminders

Intervention Type OTHER

Users of the PAML Builder application will receive reminders about three application features (copy/paste, audit trail, sort medications by class) at the startup of the application

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Reminders

Users of the PAML Builder application will receive reminders about three application features (copy/paste, audit trail, sort medications by class) at the startup of the application

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* users of the PAML Builder application (physicians, nurses, pharmacists)

Exclusion Criteria

* none
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Massachusetts General Hospital

OTHER

Sponsor Role collaborator

Brigham and Women's Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alexander Turchin

Senior Medical Informatician

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alexander Turchin, MD, MS

Role: PRINCIPAL_INVESTIGATOR

Partners HealthCare

Carol Broverman, PhD

Role: PRINCIPAL_INVESTIGATOR

Partners HealthCare

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Massachusetts General Hospital

Boston, Massachusetts, United States

Site Status

Brigham and Women's Hospital

Boston, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Poon EG, Blumenfeld B, Hamann C, Turchin A, Graydon-Baker E, McCarthy PC, Poikonen J, Mar P, Schnipper JL, Hallisey RK, Smith S, McCormack C, Paterno M, Coley CM, Karson A, Chueh HC, Van Putten C, Millar SG, Clapp M, Bhan I, Meyer GS, Gandhi TK, Broverman CA. Design and implementation of an application and associated services to support interdisciplinary medication reconciliation efforts at an integrated healthcare delivery network. J Am Med Inform Assoc. 2006 Nov-Dec;13(6):581-92. doi: 10.1197/jamia.M2142.

Reference Type BACKGROUND
PMID: 17114640 (View on PubMed)

Turchin A, Gandhi TK, Coley CM, Shubina M, Broverman C. The use of electronic medication reconciliation to establish the predictors of validity of computerized medication records. Stud Health Technol Inform. 2007;129(Pt 2):1022-6.

Reference Type BACKGROUND
PMID: 17911870 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PAMLTIPS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of Reminders on Adherence
NCT02411006 COMPLETED NA
Decision Support AMPATH
NCT01235247 UNKNOWN NA